Introduction
============

Graft failure, defined as the irreversible loss of the central transparency of the transplanted cornea, is a frustrating experience for the patient and the surgeon. Irreversible rejection, glaucoma, infection, primary failure, late endothelial failure are some of the causes of graft failure. Late endothelial failure is defined as a gradual graft decompensation without any history of a rejection episode and an apparent cause which is unresponsive to corticosteroids.

Herpes simplex virus (HSV) is a DNA virus that induces keratitis, uveitis, or retinitis in immunocompetent subjects. After invading cornea, virus established latency in trigeminal ganglion ([@b15-opth-1-127]) and can be reactivated by stimuli such as sunlight, emotional stress, fever, and corticosteroids usage ([@b1-opth-1-127]).

Herpetic infection also involves corneal endothelial cells. Most common cause of graft failure in metaherpetic recipients is the HSV reactivation ([@b17-opth-1-127]). HSV infection caused severe endothelial cell loss in corneal organ culture ([@b3-opth-1-127]) and has been implicated in some cases of primary graft failure ([@b3-opth-1-127]; [@b4-opth-1-127]; [@b6-opth-1-127]). These evidences show that HSV might be the cause of some failures of corneal grafting.

The aim of our study was to establish whether the presence of HSV, as demonstrated by polymerase chain reaction (PCR) in donor or recipient corneas in whom no previous history of herpes simplex keratitis (HSK), could correlate with graft outcome over a 18-months period.

Material and method
===================

The study adhered to the Declaration of Helsinki and Good Clinical Practice guidelines. The subjects were enrolled after Institutional Review Board approval. Written informed consent was taken from 28 recipients (12 males and 16 females; mean age 54 ± 16.2 years; age range 24--73 years), who underwent corneal transplantation between 2001 and 2004 because of pseudophakic bullous keratopathy (9 patients), keratoconus (7 patients), corneal dystrophy (4 patients), corneal opacity due to trauma (4 patients), alkali burns (2 patients), and trachoma (2 patients) ([Table 1](#t1-opth-1-127){ref-type="table"}). Written informed consent was taken from the families of cornea donors (14 males and 14 females; mean age 31.9 ± 8.6; age range 19--48 years). None of the participants had a history of HSV infection. All corneas were free of stromal scarring or epithelial defect before sampling and had an endothelial cell density of \>2000 cells/mm^2^. Donor corneal remnants and recipient corneal buttons were preserved in a clot tube at −80 °C for polymerase chain reaction (PCR) analysis.

HSV serology
------------

An enzyme-linked immunosorbent assay (ELISA) technique was used to detect anti-HSV IgG and IgM in serum samples of graft recipients.

Tissue preparation and DNA extraction
-------------------------------------

The specimens were crushed in phosphate buffered saline, and then centrifuged at 13.000 rpm for 15 minute at 20 °C. The pellets were left to stand in a digestion buffer containing 10 mM Tris-HCl, pH7.4, 100 mM NaCl, and 25 mM EDTA, 0.5% sodium dodecyl sulfate (SDS), 200 mg/ml of proteinase K for overnight at 37 °C ([@b16-opth-1-127]). After proteinase K inactivation, 0.5 ml of saturated phenol pH 8 was added. Tubes were centrifuged at 1500 g for 15 min, and supernatant was transferred to another tube. Then, phenol--chloroform--isoamyl alcohol (25:24:1 ratio) was added, and the microtubes were centrifuged at 1500 g for 15 min. Supernatant was then transferred to another tube and chloroform--isoamyl alcohol (24:1) was added and then centrifuged at 1500 g for 15 min. DNA was precipitated using absolute ethanol and ammonium acetate (7 M) at −20 °C overnight. The solution was centrifuged at 16,000 g for 20 min. After decanting the supernatant, the pellet was washed with 70% ethanol and diluted with 20 μl sterile distilled water for PCR.

Amplification
-------------

We used 50 μl of reaction mixture containing 2 U of Taq polymerase (Promega Corp., Madison, WI), 10 × PCR buffer (Tris-HCL 100 mM, pH 8.0; KCl 500 mM), 200 μM of deoxyribonucleotide triphosphate dATP, dTTP, dCTP, dGTP, for each and and 15 mM of MgCl~2~. A total of 500 ng of each DNA extract was then subjected to HSV PCR using specific primers KS30 (5^1^-TTC AAG GCC ACC ATG TAC TAC AAA GACGT-3^1^) and KS31 (5^1^-GCC GTA AAA CGG GGA CAT GTA CAC AAA GT-3^1^). Positive cases resulted in amplification of a 431-bp fragment located on the HSV glycoprotein B gene. This target sequence is specific to HSV types 1 and 2 and is known not to code for any other human herpesviruses. The PCR cycling conditions were pre-treatment at 94 °C for 3 min, followed by 35--39 cycles of denaturation at 94 °C for 1 min, annealing for 50 s, and extension at 72 °C 1 min followed by an additional 7 min at 72 °C. Purified DNA from HSV-1 McKrae strain of HSV-1 was used as a positive control, and sterile distilled water, replacing DNA, was used as a negative control. Amplicons of the expected size (431 bp) were visualized by electrophoresis with 2.0% agarose gel stained with ethidium bromide under ultraviolet light ([Figure 1](#f1-opth-1-127){ref-type="fig"}). The positive results double-checked by PCR.

Statistical analysis
--------------------

Statistical analyses were carried out by employing the Statistical Package for Social Sciences software 11.0 for Windows package software (SPSS, Inc., Chicago, IL). The Fischer's exact chi-square test was used and a p value less than 0.05 were considered as statistically significant.

Results
=======

Anti-HSV IgG was found in serum of twenty three patients (82%). Anti-HSV IgM was not detected in any. A positive test result in the HSV PCR was obtained in six out of twenty eight (21%) recipient corneal buttons and none of the donor cornea-scleral remnants. In the follow-up period four patients experienced late endothelial failure. In three of them HSV DNA were positive. Statistically significant difference was present between HSV DNA positive corneas and HSV DNA negative corneas in respect to late endothelial failure (p = 0.022). Overall results are summarized in [Table 1](#t1-opth-1-127){ref-type="table"}.

Discussion
==========

Primary HSV infection usually occurs in childhood, and seroprevalence increase with age up to 85.3% in sexually active adults ([@b10-opth-1-127]; [@b7-opth-1-127]).The HSV-1 DNA was detected in trigeminal ganglion in 74 of 121 patients (61%) in a study ([@b12-opth-1-127]). Therefore, even without a history of HSV infection, all patients are probable carrier of latent HSV virus in trigeminal ganglia.

One of important cause of corneal opacification is HSV keratitis in developing countries. Activation and centrifugal migration of latent virus from trigeminal ganglion is the pathogenesis of herpes simplex keratitis (HSK). HSV virus can also undergo latency and reactivation in the cornea as an extraneuronal site after HSK disease ([@b13-opth-1-127]; [@b14-opth-1-127]). In previous studies HSV detection rate by PCR ranged from 32% to 82% in donor cornea buttons of subjects with a past history of herpes keratitis ([@b2-opth-1-127]; [@b18-opth-1-127]; [@b9-opth-1-127]).

In corneas of clinically unsuspected herpetic keratitis patients HSV DNA was also isolated by PCR ([@b2-opth-1-127]; [@b9-opth-1-127]). In different studies this rate was documented as 36% ([@b2-opth-1-127]), and 22% ([@b9-opth-1-127]). In our study we also demonstrated that six out of twenty eight (21%) corneal transplant patient without clinically obvious herpetic keratitis were carrying latent HSV virus in their corneas.

Recurrence of a herpetic infection following corneal transplantation is the main reason for graft failure in penetrating keratoplasties for HSK ([@b17-opth-1-127]). It was shown that HSV infection cause severe endothelial cell loss ([@b3-opth-1-127]) and HSV infection was suspected as the cause of some cases of primary graft failure ([@b4-opth-1-127]; [@b6-opth-1-127]).

In patients with allograft failure without a history of HSK, an unexpected high number of HSV positive test results were found in recipient corneal buttons. Several stimuli related to corneal transplantation, such as surgical trauma, suture removal and immune reactions, the necessary application of local immunosuppression ([@b1-opth-1-127]), may reactivate the virus. In these patients, no antiviral treatment was used since no obvious clinical signs of corneal HSV infection had been observed during the process of graft failure ([@b5-opth-1-127]). In our study, three out of six HSV DNA positive recipients (50%) and one out of twenty-two DNA negative recipients (4.5%) experienced late endothelial failure that is statistically significantly different.

Screening of donor cornea culture fluid for HSV DNA, using PCR assay is not recommended. Only 3.8% of 80 corneas were positive for HSV and post transplant follow up of the three recipients revealed no evidence of HSV induced eye disease or primary graft failure ([@b11-opth-1-127]). In our study we could not demonstrate HSV DNA by PCR in any of the recipient remnants.

In conclusion presence of latent HSV virus in recipient cornea is an important risk factor for subsequent graft outcome. Therefore, even without a history of HSV keratitis, keratoplasty patient are at risk for graft failure due to HSV corneal latency.

We thank Dr. Ayhan Kubar for providing HSV McKrae strain used as positive control in the PCR analysis.

![PCR with HSV KS30 primers (431 bp amplicon) were visualized by electrophoresis with 2.0% agarose gel stained with ethidium bromide under ultraviolet light. Lane 1 and 3 positive patient corneal specimens, lane 2 and 4 negative patient corneal specimens, lane 5 positive HSV McKrae strain control.](opth-1-127f1){#f1-opth-1-127}

###### 

Summary of data recorded for the 28 corneal graft recipients

                                       **PCR**   **Graft aspect**                           
  ---- ---- -------------- ---- ------ --------- ------------------ ------- ------- ------- --------------------------
  1    48   Dystrophy      \+   2200   −         −                  clear   clear   clear   
  2    62   Pseudophakia   \+   2700   −         \+                 clear   edema   edema   Late endothelial failure
  3    65   Pseudophakia   \+   2300   −         −                  clear   clear   clear   
  4    71   Trauma         \+   2100   −         −                  clear   clear   clear   
  5    33   Keratoconus    \+   2500   −         −                  clear   clear   clear   
  6    42   Keratoconus    \+   2300   −         \+                 clear   clear   edema   Late endothelial failure
  7    32   Dystrophy      \+   2100   −         −                  clear   clear   clear   
  8    60   Pseudophakia   \+   2000   −         −                  clear   clear   clear   
  9    47   Alkali Burn    \+   2100   −         −                  clear   clear   clear   
  10   67   Trachoma       \+   2500   −         −                  clear   edema   edema   Late endothelial failure
  11   71   Pseudophakia   \+   2500   −         −                  clear   clear   clear   
  12   68   Pseudophakia   −    2600   −         −                  clear   clear   clear   
  13   70   Trauma         \+   2500   −         −                  clear   clear   clear   
  14   29   Keratoconus    \+   2300   −         −                  clear   clear   clear   
  15   73   Pseudophakia   \+   2400   −         \+                 clear   clear   clear   
  16   66   Pseudophakia   −    2300   −         \+                 clear   clear   clear   
  17   38   Keratoconus    −    2600   −         −                  clear   clear   clear   
  18   42   Keratoconus    −    2100   −         \+                 clear   clear   clear   
  19   66   Trachoma       \+   2300   −         −                  clear   clear   clear   
  20   55   Trauma         \+   2400   −         −                  clear   clear   clear   
  21   42   Dystrophy      \+   2600   −         −                  clear   clear   clear   
  22   24   Keratoconus    \+   2700   −         \+                 clear   edema   edema   Late endothelial failure
  23   30   Dystrophy      −    2900   −         −                  clear   clear   clear   
  24   71   Trauma         \+   2200   −         −                  clear   clear   clear   
  25   70   Alkali Burn    \+   2100   −         −                  clear   clear   clear   
  26   73   Pseudophakia   \+   2200   −         −                  clear   clear   clear   
  27   60   Pseudophakia   \+   2100   −         −                  clear   clear   clear   
  28   37   Keratoconus    \+   2200   −         −                  clear   clear   clear   
